OVERVIEW

GHK Basic 50 mg is a small, naturally occurring tripeptide composed of glycyl‑histidyl‑lysine, known for its regenerative and restorative effects on tissues. It is considered the base form of the copper peptide GHK‑Cu, functioning primarily to signal cells involved in repair, growth, and inflammation regulation. Laboratory and preclinical studies have demonstrated that GHK Basic can stimulate collagen and elastin production, enhance wound healing, and promote extracellular matrix remodeling. It also exhibits antioxidant and anti-inflammatory properties, which help protect cells from oxidative stress and environmental damage. Although most research has focused on the copper-bound form (GHK‑Cu), GHK Basic itself shows potential in experimental models for improving skin health, tissue repair, and cellular signaling pathways associated with aging and regeneration. Its small molecular structure allows efficient interaction with fibroblasts, keratinocytes, and other cellular targets in experimental applications.

Despite its research interest, GHK Basic 50 mg is not approved for therapeutic use by the U.S. Food and Drug Administration or other major regulatory authorities. Evidence for its effectiveness comes mainly from in vitro studies, animal models, and small preclinical trials, rather than robust human clinical research. Products containing GHK Basic are typically marketed as research compounds and are not manufactured to pharmaceutical-grade standards, meaning purity and potency can vary. Self-administration outside controlled research settings carries safety, ethical, and legal risks. Individuals interested in skin health, tissue repair, or regenerative therapies should consult qualified healthcare professionals and rely on evidence-based interventions rather than experimental peptides.